Cardiolipin or MTCH2 can serve as tBID receptors during apoptosis

• Published in: Cell death and differentiation 2016-07, Vol.23 (7), p.1165-1174
• Main Authors: Raemy, E, Montessuit, S, Pierredon, S, van Kampen, A H, Vaz, F M, Martinou, J-C
• Format: Article
• Language: English
• Subjects: 13/2; 13/31; 13/89; 14/28; 42/41; 631/80; Apoptosis; Apoptosis - drug effects; bcl-2-Associated X Protein - metabolism; BH3 Interacting Domain Death Agonist Protein - metabolism; Biochemistry; Biomedical and Life Sciences; Cardiolipins - metabolism; Cell Biology; Cell Cycle Analysis; Cell death; Chromatography, Thin Layer; Cytochrome; Cytochromes c - metabolism; Down-Regulation - drug effects; Galactose - pharmacology; Glucose - pharmacology; HCT116 Cells; Humans; Life Sciences; Lipids; Lipids - analysis; Lipids - isolation & purification; Mass Spectrometry; Membrane Proteins - genetics; Membrane Proteins - metabolism; Microscopy, Fluorescence; Mitochondria; Mitochondria - drug effects; Mitochondria - metabolism; Mitochondria - pathology; Mitochondrial Membrane Transport Proteins - metabolism; Mitochondrial Membranes - metabolism; Original Paper; Oxidative Phosphorylation - drug effects; Phosphorylation; Proteins; Stem Cells; TNF-Related Apoptosis-Inducing Ligand - pharmacology
• ISSN: 1350-9047; 1476-5403
• DOI: 10.1038/cdd.2015.166

During apoptosis, proapoptotic BAX and BAK trigger mitochondrial outer membrane (MOM) permeabilization by a mechanism that is not yet fully understood. BH3-only proteins such as tBID, together with lipids of the MOM, are thought to play a key role in BAX and BAK activation. In particular, cardiolipin (CL) has been shown to stimulate tBID-induced BAX activation in vitro . However, it is still unclear whether this process also relies on CL in the cell, or whether it is more dependent on MTCH2, a proposed receptor for tBID present in the MOM. To address this issue, we deleted both alleles of cardiolipin synthase in human HCT116 cells by homologous recombination, which resulted in a complete absence of CL. The CL-deficient cells were fully viable in glucose but displayed impaired oxidative phosphorylation and an inability to grow in galactose. Using these cells, we found that CL was not required for either tBID-induced BAX activation, or for apoptosis in response to treatment with TRAIL. Downregulation of MTCH2 in HCT116 cells also failed to prevent recruitment of tBID to mitochondria in apoptotic conditions. However, when both CL and MTCH2 were depleted, a significant reduction in tBID recruitment was observed, suggesting that in HCT116 cells, CL and MTCH2 can have redundant functions in this process.